Inhaled beclomethasone in the treatment of early COVID-19: a phase 2, double-blind, placebo-controlled, randomised trial

Simple item page
dc.contributor.authorMettananda, C,
dc.contributor.authorPeiris, C.
dc.contributor.authorAbeyrathna, D.
dc.contributor.authorGunasekera, A.
dc.contributor.authorEgodage, T.
dc.contributor.authorDanthanarayana, C.
dc.contributor.authorPathmeswaran, A.
dc.contributor.authorRanasinha, C.
dc.date.accessioned2024-01-09T09:23:15Z
dc.date.available2024-01-09T09:23:15Z
dc.date.issued2023
dc.descriptionIndexed in MEDLINEen_US
dc.description.abstractNo abstract availableen_US
dc.identifier.citationClinical Medicine.2023;23(Suppl 6):66-68en_US
dc.identifier.issn1470-2118 (Print)
dc.identifier.issn1473-4893 (Electronic)
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/27178
dc.language.isoenen_US
dc.publisherThe Collegeen_US
dc.subjectCOVID-19en_US
dc.titleInhaled beclomethasone in the treatment of early COVID-19: a phase 2, double-blind, placebo-controlled, randomised trialen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
52 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Journal/Magazine Articles